SlideShare a Scribd company logo
1 of 35
Download to read offline
Risk adjustment opportunities
                        and challenges:
                    US and UK experiences
                               Professor Jonathan P. Weiner
                           Johns Hopkins Bloomberg School of Public Health
                                      Baltimore Maryland, USA
                                         Jweiner@jhsph.edu

                    Presented at Nuffield Trust Conference, London, 29/6/11

© Copyright 2011 Johns Hopkins University,.
A bit about me                                         2


                                               Jonathan Weiner, DrPH
                                                 From The Johns Hopkins
                                                  University
                                                  Professor of Health Policy &
                                                   Management
                                                  Professor of Health
                                                   Informatics
                                                  CEO of the Johns Hopkins
                                                   ACG R&D Team, based at
                                                   University

© Copyright 2011, Johns Hopkins University,.
During the next 25 minutes I will offer some
                      insights into:                                 3

          • The conceptual domains of risk adjustment / case-mix
            / predictive modeling.

          • The Johns Hopkins ACG risk adjustment / predictive
            modeling method.

          • Experiences with risk adjustment applications in the
            US & UK related to budgeting / financing and beyond.

          • Some issues, opportunities and challenges
            associated with risk adjustment in the English primary
            care context.
© Copyright 2011, Johns Hopkins University,.
Risk adjustment is necessary because not all
              persons have the same need for health care                 4



                                                     Percent of Health
                                      Percent of
                                                     Care Resources
                                      Population
                                                        Consumed

                                               1%          30%
                                               10%         70%
                                               50%         97%




© Copyright 2011, Johns Hopkins University,.
Working Definitions                                  5

         • Case mix / risk adjustment (RA) -        taking
              health status / risk into consideration for health
              care finance, payment, provider performance
              assessment and patient outcome monitoring.

         • Predictive modeling (PM)          - prospective (or
              concurrent) application of risk measures and
              statistical technique to identify “high risk”
              individuals who would likely benefit from care
              management interventions.

                                                        5
© Copyright 2011, Johns Hopkins University,.
Co-Morbidity is key – Multiple morbidities
         encountered in UK GP practices                                             6
                            Average consultation in elderly involves someone with
                            1.9 QOF diseases and 6.7 chronic diseases using
                            ACG/EDC chronic disease designations




       Source: Salisbury et al. From GPRD data, 488 practices 2005-2008
© Copyright 2011, Johns Hopkins University,.
Co-morbidities are the norm for those
                       with common “index” chronic conditions                                                          7
                       (US 65+)

                     Diabetes             9%           22%            21%             21%              27%



            Heart Disease                 11%           21%             25%                 24%           19%



                     Arthritis             12%           22%             23%               22%           21%



            Hypertension                       17%            24%              23%            20%          16%



                                   0%                 20%            40%             60%          80%           100%
                      Single Condition               Condition + 1   Condition + 2    Condition + 3   Condition + 4+


        Source: From US Medicare (65+) data . Partnership for Solutions, Johns Hopkins University
© Copyright 2011, Johns Hopkins University,.
Co-morbidities are central to understanding
                     resource use: ACG risk levels and patterns of                                            8
                            resource use at an English PCT

              Level of Co-                     % of    Hospital    Est. % of         Avg. #        Avg. #
              morbidity                        PCT’s     Use      Admissions          Out-       Prescripti
              (Based on                        Pop.    Relative     at PCT           Patient      ons / Yr.
              ACGs)                                     Ratio                       Episodes
                                                                                      / Yr.
              High                               2%       11.5            25%             11.0          93
              Moderate                          17%        3.0            47%              7.1          66
              Low                               40%         .6            26%              3.0          28
              None                              41%        >.1              2%              .5           6


          Data from several large GP practices within PCT for 2005. N= 20,500 all ages.


© Copyright 2011, Johns Hopkins University,.
                                                                                                         8
Johns Hopkins ACGs - 1                            9

              • One of first case-mix / risk adjustment method for
                categorizing diagnosis codes outside of hospitals.
              • 30 years of ongoing R&D at Johns Hopkins.
              • Original version based on primary care morbidity
                patterns (ADGs) developed by Prof. Barbara Starfield.
              • Billions of dollars per year are now routinely
                exchanged using ACGs in US, Canada, Spain,
                Sweden and other nations.
              • Care of 80+ million patients is budgeted, managed and
                monitored using ACGs in 16+ nations.



© Copyright 2011, Johns Hopkins University,.
Johns Hopkins ACGs - 2                               10


                       • Comprehensive measure of a population’s risk and
                         morbidity burden. They do not just categorize
                         organ system-based diseases.
                       • Roots were primary care / population based.
                       • New collaboration with WONCA to integrate ACGs
                         with ICPC.
                       • Method owned and maintained by University.
                       • There is a comprehensive computerized suite of
                         ACG measures using most international diagnosis
                         and pharmacy codes.


© Copyright 2011, Johns Hopkins University,.
Key components of the Johns Hopkins ACG
              System (www.acg.jhsph.edu)                                                    11

                                                          ADGs
                                                           32
         Patient Info
            ID – Age – Gender –
               Resource Use                              ACGs
                                                            102 / 6


           Diagnosis                            ACG      EDCs                  Predictive
       Read- ICD 9 - ICD 10 - ICPC
                                               System      220 / 30             Models

                                                         Markers
                                                        Frailty – Hosdom –
                                                              Chronic
        Pharmaceuticals                                 Pregnancy - Delivery

           ATC, Read, BNF

                                                        Rx-MG
                                                               60

© Copyright 2011, Johns Hopkins University,.
ACG System Use in the NHS
                 (Currently 6+ million pts. across 12 PCTs)                    12

               • 2001 - Academic research at UCL and Imperial
                      using GPRD data.
               •      2005 – Initial pilot project with 3 PCTs (w/ Imperial)
               •      2007 – Collaborated with King’s Fund on the Person
                      Based Resource Allocation (PBRA) project
               •      2008 – Ashton, Leigh, and Wigan PCT
               •      2009 –North Yorkshire and York PCTs
               •      2010 – South Central – 9 PCTs (150 practices with
                      uptake increasing)
               •      2011- Sutton & Merton PCT
               •      Universities: Imperial College, UCL, Bristol,
                      Manchester, Glasgow.
               •      Several academics groups and many other PCTs /
                      NHS organizations have expressed interest.
© Copyright 2011, Johns Hopkins University,.
The Risk Adjustment “Application
                      Pyramid”                                                                 13

                                                         Management Applications
                                          High      Case-
                                         Disease
                                                 Management
                                         Burden
                                                               Disease                    Needs
                                   Single High                Management     Practice
                                                                                        Assessment
                                     Impact                                 Resource
                                     Disease                               Management
                                                                                          Quality
                                                                                        Improvement

                                          Users                                          Payment/
                                                                                         Finance

                       Users & Non-Users


             Population Segment

© Copyright 2011, Johns Hopkins University,.
Types of risk adjustment
                   applications within health care                                          14

                    Financing, Payment,                Care Management
                     Planning                                Identification of high risk
                       Morbidity-adjusted                    patient
                        capitation                              Disease management
                            Allocation of budgets              Case management

                            Service targets            Quality
                       Forecasting healthcare               Quality assessment
                        spending                             Quality monitoring
                    Provider Performance               Research and Program
                     Assessment
                                                         Evaluation
                       Profiling

                            Pay-for-Performance


© Copyright 2011, Johns Hopkins University,.
15




                                       FINANCING, PAYMENT,
                                       RESOURCE PLANNING




© Copyright 2011, Johns Hopkins University,.
Resource Use Varies by Risk of GP Patients: NHS
          Consultant Referral Rates by Morbidity Score                              16


                                           50

                                           40
       % Patients
       referred per
       year to one
                                           30
       or more
       consultants
                                           20
                                           10
                                                0.5   1.0     1.5       2.0   2.5

                                                  ACG Morbidity Score

       Source: Forrest, Majeed, Weiner, et al. BMJ 2002:
       325;370
© Copyright 2011, Johns Hopkins University,.
                                                                               16
Morbidity Risk Scores (RUBs) Across
GP practices in a PCT
And these risk levels vary across communities
served by practices in this PCT
State of Minnesota “Health Care Home” program pays
            a monthly care coordination fee based on 5 patient
            complexity tiers
                                                               19




      Source: Minnesota Department of Health 2010.
      PMPM = per member per month.
      Patient complexity tiers based on ACG/EDC categories.
© Copyright 2011, Johns Hopkins University,.
Maryland Medicaid risk adjusted (ACG) payment to
         capitated “HMO” health plans                                                            20




                                                                                         Average
                                                                                          Risk




 Using ACGs, risk ratios were determined for each contracting managed care organization /
 health plan. Expected values were determined separately for the two enrollee groups with this
 State Medicaid program.


© Copyright 2011, Johns Hopkins University,.
Some potential financial applications within context of
         English PCTs, GPCCs, Clusters, GP practices (etc.)      21

         • Setting aspects of budgets for GP Consortia / GP
              practices.
         •    To help GPCCs determine the budgets for downstream
              health care commissioning.
         •    Monitor resource use and adjusting various pay for
              performance “P4P” performance measures.
         •    Special payment to GPs or others for special need
              patients.
         •    Adjusting/stratifying cases or episode payments as part of
              commissioning of secondary services.




© Copyright 2011, Johns Hopkins University,.
22




                        PROVIDER PERFORMANCE
                             ASSESSMENT




© Copyright 2011, Johns Hopkins University,.
Risk-Adjusted O/E (Efficiency) Profiling Ratios
          for GPs Across a Primary Care Trust (PCT) in UK 23
                   2.0

                   1.8

                   1.6

                   1.4

                   1.2

                   1.0

                   0.8

                   0.6

                   0.4

                   0.2

                   0.0
                             GP1 GP2 GP3 GP4 GP5 GP6 GP7 GP8                        GP9 GP10 GP11 GP12
                               No of referrals No of unique prescriptions / month   No of unique radiology tests

 Observed = actual avg. use by patients.
 Expected = based on ACG case-mix of pts.                            Above 1.0 = higher than expected.
© Copyright 2011, Johns Hopkins University,.
Comparison of Risk Adusted (ACG) and
                    Age/Gender-based O:E Ratios for GPs across   24
                    Province of British Columbia Canada




© Copyright 2011, Johns Hopkins University,.
25


                              CARE MANAGEMENT AND
                                HIGH RISK PATIENT
                                  IDENTIFICATION




© Copyright 2011, Johns Hopkins University,.
Using risk stratification to target disease management program
          participation for chronic conditions
                                                                                                  26

                                        % Enrollees in ACG Risk    Resource Use of Cohort
                                               Category           Relative to Total Population
      Condition of                        Low     Med.   High      Low       Med.       High
      Interest




      Diabetes                            44.97   42.1    11.9     1.34       4.90      7.44


      Congestive
      Heart                               19.75   53.5   26.75     1.14       6.02      7.93
      Failure


                                                                  Tier 1 Tier 2 Tier 3

© Copyright 2011, Johns Hopkins University,.
                                                                                                 26
Long-term conditions for GP practice by RUB co
morbidity strata
Care Management ACG report for a GP’s “high
risk” Patient in GPCC / PCT
Possible applications of PM / RA for
               improving care & accountability in England               29

               • To comprehensively assess the needs of
                    communities and special populations
                         •     Long-term (chronic) conditions
                         •     Disparities / social need.

               • To support “predictive” case finding to improve
                    coordination and avoid unnecessary hospital and
                    other types of care.

               • By regulators /evaluators to fairly monitor outcomes
                    and financial performance.



© Copyright 2011, Johns Hopkins University,.
30


                                               SOME ISSUES AND
                                                OBSERVATIONS




© Copyright 2011, Johns Hopkins University,.
Data Accuracy Issues: Condition identification using GP
 diagnosis and pharmacy data from EMRs. Also
                                                                                                         31
 comparison to US results using 1º + 2º provider claims.

                                                                                                 % UK
                                                              % UK and US        % UK          patients
                                                                 patients       patients       uniquely
                   Condition                                    identified   identified by   identified by
                                                                 (ICD or          GP              GP
                                                                 pharm.)      diagnoses*     prescriptions
                                               Hypertension     13%, 19%         5.0%            8.1%
        Disorders of Lipoid metabolism                          5%, 15%          1.5%            3.8%
                                                       CHF       3%, 2%          .2%             2.3%
                                                    Asthma      9%, 10%          4.4%            4.4%
                                                Depression      6%, 10%          1.6%            4.6%
                                                   Diabetes      4%, 5%          3.9%            .1%

       UK results from two PCTs w/2005 data, n=500K, based on ACG’s EDCs and
       RxMGs. US results based on 2M health plan sample using both primary and
       secondary care claims. *Many pts. had both diagnosis and pharmacy codes.

© Copyright 2011, Johns Hopkins University,.
NHS Reform will lead to opportunities for expanding
              the use of risk adjustment and predictive modeling
              tools                                               32


       • The English reform plans include many shifts in paradigms
            that will enable RA and PM tools to have a positive impact
            on system efficiency, effectiveness and equity.

       • Many innovations are possible in English context that
            could allow us to improve the state-of-the-art of risk
            adjustment (e.g., social care integration, application of
            electronic patient records).

       • There is considerable overlap between GPCCs and
            aspects of past and current US reform. There are lessons
            and synergies in risk adjustment domain and beyond.

© Copyright 2011, Johns Hopkins University,.
There will also be challenges related to the
       application of RA/PM                                                33

              • Need to integrate risk adjustment / predictive modeling
                  into dynamically changing (and charged) administrative
                  and fiscal situation.

              • There will be many challenges associated with
                  integrating and using data that previously had other
                  purposes.

              • Some cautions: be wary of “code creep”, maintaining
                  zero sum game, negative impact of potential pharmacy
                  code gaming.

© Copyright 2011, Johns Hopkins University,.
Need for risk adjustment is universal, but of course all of
     this will be impacted by future polices in both nations 34




© Copyright 2011, Johns Hopkins University,.
                                                          34
For more information on Johns Hopkins
                    experiences and tools                                 35


            • Johns Hopkins web site:
                      – www.acg.jhsph.edu
            • Contacts:
                      – Dr. Karen Kinder: Director, ACG International
                        (Based in Germany) kkinder@jhsph.edu
                         – Steve Sutch: Senior ACG Consultant (based in
                              England) ssutch@jhsph.edu



© Copyright 2011, Johns Hopkins University,.

More Related Content

What's hot

The story of personalized medicine
The story of personalized medicineThe story of personalized medicine
The story of personalized medicineSeth Taylor
 
Benzodiazepines & risk of mortality
Benzodiazepines & risk of mortalityBenzodiazepines & risk of mortality
Benzodiazepines & risk of mortalityPaul Coelho, MD
 
Kachalia 2007 missed and delayed diagnoses in the emergency department
Kachalia 2007 missed and delayed diagnoses in the emergency departmentKachalia 2007 missed and delayed diagnoses in the emergency department
Kachalia 2007 missed and delayed diagnoses in the emergency departmentJuliacho Rodriguez Rodriguez
 
Interphone and beyond evidence for harm or safety armstrong
Interphone and beyond evidence for harm or safety  armstrongInterphone and beyond evidence for harm or safety  armstrong
Interphone and beyond evidence for harm or safety armstrongLeishman Associates
 
Contemporary Management of HIV. New Data From IDWeek 2018 and Other Fall 2018...
Contemporary Management of HIV. New Data From IDWeek 2018 and Other Fall 2018...Contemporary Management of HIV. New Data From IDWeek 2018 and Other Fall 2018...
Contemporary Management of HIV. New Data From IDWeek 2018 and Other Fall 2018...hivlifeinfo
 
Chapter 15 precision medicine in oncology
Chapter 15 precision medicine in oncologyChapter 15 precision medicine in oncology
Chapter 15 precision medicine in oncologyNilesh Kucha
 
Guidance for Biomarkers into Early Phase Clinical Research Purposes | Healthc...
Guidance for Biomarkers into Early Phase Clinical Research Purposes | Healthc...Guidance for Biomarkers into Early Phase Clinical Research Purposes | Healthc...
Guidance for Biomarkers into Early Phase Clinical Research Purposes | Healthc...PEPGRA Healthcare
 
Day 1: 1:00pm- 2:30pm Panel Slides (Nov 18) Access to Innovation Conference 2...
Day 1: 1:00pm- 2:30pm Panel Slides (Nov 18) Access to Innovation Conference 2...Day 1: 1:00pm- 2:30pm Panel Slides (Nov 18) Access to Innovation Conference 2...
Day 1: 1:00pm- 2:30pm Panel Slides (Nov 18) Access to Innovation Conference 2...Canadian Organization for Rare Disorders
 
Clinical Genomics and Medicine
Clinical Genomics and MedicineClinical Genomics and Medicine
Clinical Genomics and MedicineWarren Kibbe
 
IAS_NetworkNewsletter
IAS_NetworkNewsletterIAS_NetworkNewsletter
IAS_NetworkNewsletterMaggie Pajak
 
Personalized Medicine's Effect on Oncologists' Treatment Regimens
Personalized Medicine's Effect on Oncologists' Treatment RegimensPersonalized Medicine's Effect on Oncologists' Treatment Regimens
Personalized Medicine's Effect on Oncologists' Treatment RegimensIndustry Standard Research
 
23204998
2320499823204998
23204998radgirl
 
Patterns of opioid use and risk of opioid overdose.
Patterns of opioid use and risk of opioid overdose.Patterns of opioid use and risk of opioid overdose.
Patterns of opioid use and risk of opioid overdose.Paul Coelho, MD
 
Resident Work Hours To AMSA National 2005
Resident Work Hours To AMSA National 2005Resident Work Hours To AMSA National 2005
Resident Work Hours To AMSA National 2005mdmendoz
 

What's hot (19)

The story of personalized medicine
The story of personalized medicineThe story of personalized medicine
The story of personalized medicine
 
Benzodiazepines & risk of mortality
Benzodiazepines & risk of mortalityBenzodiazepines & risk of mortality
Benzodiazepines & risk of mortality
 
LDI Research Seminar- Targeted Testing & Treatment for Breast Cancer 11_18_11
LDI Research Seminar- Targeted Testing & Treatment for Breast Cancer 11_18_11LDI Research Seminar- Targeted Testing & Treatment for Breast Cancer 11_18_11
LDI Research Seminar- Targeted Testing & Treatment for Breast Cancer 11_18_11
 
Kachalia 2007 missed and delayed diagnoses in the emergency department
Kachalia 2007 missed and delayed diagnoses in the emergency departmentKachalia 2007 missed and delayed diagnoses in the emergency department
Kachalia 2007 missed and delayed diagnoses in the emergency department
 
Benzo's & Opioids
Benzo's & OpioidsBenzo's & Opioids
Benzo's & Opioids
 
Interphone and beyond evidence for harm or safety armstrong
Interphone and beyond evidence for harm or safety  armstrongInterphone and beyond evidence for harm or safety  armstrong
Interphone and beyond evidence for harm or safety armstrong
 
Contemporary Management of HIV. New Data From IDWeek 2018 and Other Fall 2018...
Contemporary Management of HIV. New Data From IDWeek 2018 and Other Fall 2018...Contemporary Management of HIV. New Data From IDWeek 2018 and Other Fall 2018...
Contemporary Management of HIV. New Data From IDWeek 2018 and Other Fall 2018...
 
Chapter 15 precision medicine in oncology
Chapter 15 precision medicine in oncologyChapter 15 precision medicine in oncology
Chapter 15 precision medicine in oncology
 
Integrating Genomic Medicine into Patient Care with Trish Brown, MS, CGC
Integrating Genomic Medicine into Patient Care with Trish Brown, MS, CGCIntegrating Genomic Medicine into Patient Care with Trish Brown, MS, CGC
Integrating Genomic Medicine into Patient Care with Trish Brown, MS, CGC
 
Guidance for Biomarkers into Early Phase Clinical Research Purposes | Healthc...
Guidance for Biomarkers into Early Phase Clinical Research Purposes | Healthc...Guidance for Biomarkers into Early Phase Clinical Research Purposes | Healthc...
Guidance for Biomarkers into Early Phase Clinical Research Purposes | Healthc...
 
Day 1: 1:00pm- 2:30pm Panel Slides (Nov 18) Access to Innovation Conference 2...
Day 1: 1:00pm- 2:30pm Panel Slides (Nov 18) Access to Innovation Conference 2...Day 1: 1:00pm- 2:30pm Panel Slides (Nov 18) Access to Innovation Conference 2...
Day 1: 1:00pm- 2:30pm Panel Slides (Nov 18) Access to Innovation Conference 2...
 
Clinical Genomics and Medicine
Clinical Genomics and MedicineClinical Genomics and Medicine
Clinical Genomics and Medicine
 
Global precision medicine market (2018-2023)
Global precision medicine market (2018-2023)Global precision medicine market (2018-2023)
Global precision medicine market (2018-2023)
 
IAS_NetworkNewsletter
IAS_NetworkNewsletterIAS_NetworkNewsletter
IAS_NetworkNewsletter
 
Personalized Medicine's Effect on Oncologists' Treatment Regimens
Personalized Medicine's Effect on Oncologists' Treatment RegimensPersonalized Medicine's Effect on Oncologists' Treatment Regimens
Personalized Medicine's Effect on Oncologists' Treatment Regimens
 
Bupe vs No Bupe
Bupe vs No BupeBupe vs No Bupe
Bupe vs No Bupe
 
23204998
2320499823204998
23204998
 
Patterns of opioid use and risk of opioid overdose.
Patterns of opioid use and risk of opioid overdose.Patterns of opioid use and risk of opioid overdose.
Patterns of opioid use and risk of opioid overdose.
 
Resident Work Hours To AMSA National 2005
Resident Work Hours To AMSA National 2005Resident Work Hours To AMSA National 2005
Resident Work Hours To AMSA National 2005
 

Similar to Jonathan Weiner: Risk adjustment opportunities and challenges: US and UK experiences

Final ppahs notre dame presentation
Final ppahs notre dame presentationFinal ppahs notre dame presentation
Final ppahs notre dame presentationMike Wong
 
Practicum Presentation
Practicum PresentationPracticum Presentation
Practicum Presentationguest231e1f
 
Healthy Chicago's Focus on Communicable Diseases, Healthcare-associated infec...
Healthy Chicago's Focus on Communicable Diseases, Healthcare-associated infec...Healthy Chicago's Focus on Communicable Diseases, Healthcare-associated infec...
Healthy Chicago's Focus on Communicable Diseases, Healthcare-associated infec...Chicago Department of Public Health
 
Journal Article Analysis: Medication Errors in Overweight and Obese Pediatric...
Journal Article Analysis: Medication Errors in Overweight and Obese Pediatric...Journal Article Analysis: Medication Errors in Overweight and Obese Pediatric...
Journal Article Analysis: Medication Errors in Overweight and Obese Pediatric...Paul Pasco
 
Research Ethics Forum: Ethical Challenges in Trials of Human Genome Editing a...
Research Ethics Forum: Ethical Challenges in Trials of Human Genome Editing a...Research Ethics Forum: Ethical Challenges in Trials of Human Genome Editing a...
Research Ethics Forum: Ethical Challenges in Trials of Human Genome Editing a...SC CTSI at USC and CHLA
 
Randall Ellis: Risk-based comprehensive payment for primary care
Randall Ellis: Risk-based comprehensive payment for primary careRandall Ellis: Risk-based comprehensive payment for primary care
Randall Ellis: Risk-based comprehensive payment for primary careNuffield Trust
 
Molecular Epidemiology of NCD.pptx
Molecular Epidemiology of NCD.pptxMolecular Epidemiology of NCD.pptx
Molecular Epidemiology of NCD.pptxSantoshi Paudel
 
Molecular Epidemiology of NCD.pptx
Molecular Epidemiology of NCD.pptxMolecular Epidemiology of NCD.pptx
Molecular Epidemiology of NCD.pptxSantoshi Paudel
 
How evidence affects clinical practice in egypt
How evidence affects clinical practice in egyptHow evidence affects clinical practice in egypt
How evidence affects clinical practice in egyptWafaa Benjamin
 
Quality of Life of the Filipino Cancer Patient
Quality of Life of the Filipino Cancer PatientQuality of Life of the Filipino Cancer Patient
Quality of Life of the Filipino Cancer PatientMary Ondinee Manalo Igot
 
Lessons learned in polygenic risk research | Grand Rapids, MI 2019
Lessons learned in polygenic risk research | Grand Rapids, MI 2019Lessons learned in polygenic risk research | Grand Rapids, MI 2019
Lessons learned in polygenic risk research | Grand Rapids, MI 2019Cecile Janssens
 
ENRS_Smith_Poster.ppt
ENRS_Smith_Poster.pptENRS_Smith_Poster.ppt
ENRS_Smith_Poster.pptFiNi17
 
Jowett matthew - Innovation in other sectors
Jowett matthew - Innovation in other sectorsJowett matthew - Innovation in other sectors
Jowett matthew - Innovation in other sectorsponencias_mihealth2012
 
bevacizumab chemotherapy treatment of metastastic colorectal cancer metasta...
 bevacizumab  chemotherapy treatment of metastastic colorectal cancer metasta... bevacizumab  chemotherapy treatment of metastastic colorectal cancer metasta...
bevacizumab chemotherapy treatment of metastastic colorectal cancer metasta...Мандухай Г.
 
10 STRATEGIC POINTS2Ten Strategic Points .docx
10 STRATEGIC POINTS2Ten Strategic Points .docx10 STRATEGIC POINTS2Ten Strategic Points .docx
10 STRATEGIC POINTS2Ten Strategic Points .docxaulasnilda
 
A tiered approach to integrating genomic tests into
A tiered approach to integrating genomic tests intoA tiered approach to integrating genomic tests into
A tiered approach to integrating genomic tests intoChau Nguyen
 
NIPHC IPLAN Indicators
NIPHC IPLAN IndicatorsNIPHC IPLAN Indicators
NIPHC IPLAN IndicatorsChris Mickens
 

Similar to Jonathan Weiner: Risk adjustment opportunities and challenges: US and UK experiences (20)

Final ppahs notre dame presentation
Final ppahs notre dame presentationFinal ppahs notre dame presentation
Final ppahs notre dame presentation
 
Practicum Presentation
Practicum PresentationPracticum Presentation
Practicum Presentation
 
Healthy Chicago's Focus on Communicable Diseases, Healthcare-associated infec...
Healthy Chicago's Focus on Communicable Diseases, Healthcare-associated infec...Healthy Chicago's Focus on Communicable Diseases, Healthcare-associated infec...
Healthy Chicago's Focus on Communicable Diseases, Healthcare-associated infec...
 
10 year risk of chd
10 year risk of chd10 year risk of chd
10 year risk of chd
 
Journal Article Analysis: Medication Errors in Overweight and Obese Pediatric...
Journal Article Analysis: Medication Errors in Overweight and Obese Pediatric...Journal Article Analysis: Medication Errors in Overweight and Obese Pediatric...
Journal Article Analysis: Medication Errors in Overweight and Obese Pediatric...
 
Research Ethics Forum: Ethical Challenges in Trials of Human Genome Editing a...
Research Ethics Forum: Ethical Challenges in Trials of Human Genome Editing a...Research Ethics Forum: Ethical Challenges in Trials of Human Genome Editing a...
Research Ethics Forum: Ethical Challenges in Trials of Human Genome Editing a...
 
HIV-HCV coinfection: still special in 2015?
HIV-HCV coinfection: still special in 2015?HIV-HCV coinfection: still special in 2015?
HIV-HCV coinfection: still special in 2015?
 
Randall Ellis: Risk-based comprehensive payment for primary care
Randall Ellis: Risk-based comprehensive payment for primary careRandall Ellis: Risk-based comprehensive payment for primary care
Randall Ellis: Risk-based comprehensive payment for primary care
 
Molecular Epidemiology of NCD.pptx
Molecular Epidemiology of NCD.pptxMolecular Epidemiology of NCD.pptx
Molecular Epidemiology of NCD.pptx
 
Molecular Epidemiology of NCD.pptx
Molecular Epidemiology of NCD.pptxMolecular Epidemiology of NCD.pptx
Molecular Epidemiology of NCD.pptx
 
How evidence affects clinical practice in egypt
How evidence affects clinical practice in egyptHow evidence affects clinical practice in egypt
How evidence affects clinical practice in egypt
 
Quality of Life of the Filipino Cancer Patient
Quality of Life of the Filipino Cancer PatientQuality of Life of the Filipino Cancer Patient
Quality of Life of the Filipino Cancer Patient
 
Medication error
Medication errorMedication error
Medication error
 
Lessons learned in polygenic risk research | Grand Rapids, MI 2019
Lessons learned in polygenic risk research | Grand Rapids, MI 2019Lessons learned in polygenic risk research | Grand Rapids, MI 2019
Lessons learned in polygenic risk research | Grand Rapids, MI 2019
 
ENRS_Smith_Poster.ppt
ENRS_Smith_Poster.pptENRS_Smith_Poster.ppt
ENRS_Smith_Poster.ppt
 
Jowett matthew - Innovation in other sectors
Jowett matthew - Innovation in other sectorsJowett matthew - Innovation in other sectors
Jowett matthew - Innovation in other sectors
 
bevacizumab chemotherapy treatment of metastastic colorectal cancer metasta...
 bevacizumab  chemotherapy treatment of metastastic colorectal cancer metasta... bevacizumab  chemotherapy treatment of metastastic colorectal cancer metasta...
bevacizumab chemotherapy treatment of metastastic colorectal cancer metasta...
 
10 STRATEGIC POINTS2Ten Strategic Points .docx
10 STRATEGIC POINTS2Ten Strategic Points .docx10 STRATEGIC POINTS2Ten Strategic Points .docx
10 STRATEGIC POINTS2Ten Strategic Points .docx
 
A tiered approach to integrating genomic tests into
A tiered approach to integrating genomic tests intoA tiered approach to integrating genomic tests into
A tiered approach to integrating genomic tests into
 
NIPHC IPLAN Indicators
NIPHC IPLAN IndicatorsNIPHC IPLAN Indicators
NIPHC IPLAN Indicators
 

More from Nuffield Trust

Transforming outpatient services - Nuffield Trust/NHS Improvement Event
Transforming outpatient services - Nuffield Trust/NHS Improvement EventTransforming outpatient services - Nuffield Trust/NHS Improvement Event
Transforming outpatient services - Nuffield Trust/NHS Improvement EventNuffield Trust
 
13 reasons to spend more on health and social care
13 reasons to spend more on health and social care 13 reasons to spend more on health and social care
13 reasons to spend more on health and social care Nuffield Trust
 
Energising your workforce in the face of adversity
Energising your workforce in the face of adversityEnergising your workforce in the face of adversity
Energising your workforce in the face of adversityNuffield Trust
 
Shifting the balance of care: great expectations
Shifting the balance of care: great expectations Shifting the balance of care: great expectations
Shifting the balance of care: great expectations Nuffield Trust
 
Automation, Employment, and Health Care
Automation, Employment, and Health Care Automation, Employment, and Health Care
Automation, Employment, and Health Care Nuffield Trust
 
Public perspectives on the NHS and social care
Public perspectives on the NHS and social carePublic perspectives on the NHS and social care
Public perspectives on the NHS and social careNuffield Trust
 
Evaluation of the Integrated Care and Support Pioneers Programme
Evaluation of the Integrated Care and Support Pioneers ProgrammeEvaluation of the Integrated Care and Support Pioneers Programme
Evaluation of the Integrated Care and Support Pioneers ProgrammeNuffield Trust
 
Ensuring success for new models of care
Ensuring success for new models of careEnsuring success for new models of care
Ensuring success for new models of careNuffield Trust
 
Effectiveness of the current dominant approach to integrated care in the NHS
Effectiveness of the current dominant approach to integrated care in the NHSEffectiveness of the current dominant approach to integrated care in the NHS
Effectiveness of the current dominant approach to integrated care in the NHSNuffield Trust
 
Providing actionable healthcare analytics at scale: Understanding improvement...
Providing actionable healthcare analytics at scale: Understanding improvement...Providing actionable healthcare analytics at scale: Understanding improvement...
Providing actionable healthcare analytics at scale: Understanding improvement...Nuffield Trust
 
Local and national uses of data
Local and national uses of dataLocal and national uses of data
Local and national uses of dataNuffield Trust
 
Applied use of CUSUMs in surveillance
Applied use of CUSUMs in surveillanceApplied use of CUSUMs in surveillance
Applied use of CUSUMs in surveillanceNuffield Trust
 
Evaluating new models of care: Improvement Analytics Unit
Evaluating new models of care: Improvement Analytics UnitEvaluating new models of care: Improvement Analytics Unit
Evaluating new models of care: Improvement Analytics UnitNuffield Trust
 
Learning from the Care Quality Commission
Learning from the Care Quality CommissionLearning from the Care Quality Commission
Learning from the Care Quality CommissionNuffield Trust
 
Real-time monitoring and the data trap
Real-time monitoring and the data trapReal-time monitoring and the data trap
Real-time monitoring and the data trapNuffield Trust
 
Monitoring quality of care: making the most of data
Monitoring quality of care: making the most of dataMonitoring quality of care: making the most of data
Monitoring quality of care: making the most of dataNuffield Trust
 
Providing actionable healthcare analytics at scale: Insights from the Nationa...
Providing actionable healthcare analytics at scale: Insights from the Nationa...Providing actionable healthcare analytics at scale: Insights from the Nationa...
Providing actionable healthcare analytics at scale: Insights from the Nationa...Nuffield Trust
 
Providing actionable healthcare analytics at scale: A perspective from stroke...
Providing actionable healthcare analytics at scale: A perspective from stroke...Providing actionable healthcare analytics at scale: A perspective from stroke...
Providing actionable healthcare analytics at scale: A perspective from stroke...Nuffield Trust
 
New Models of General Practice: Practical and policy lessons
New Models of General Practice: Practical and policy lessonsNew Models of General Practice: Practical and policy lessons
New Models of General Practice: Practical and policy lessonsNuffield Trust
 

More from Nuffield Trust (20)

Transforming outpatient services - Nuffield Trust/NHS Improvement Event
Transforming outpatient services - Nuffield Trust/NHS Improvement EventTransforming outpatient services - Nuffield Trust/NHS Improvement Event
Transforming outpatient services - Nuffield Trust/NHS Improvement Event
 
13 reasons to spend more on health and social care
13 reasons to spend more on health and social care 13 reasons to spend more on health and social care
13 reasons to spend more on health and social care
 
Energising your workforce in the face of adversity
Energising your workforce in the face of adversityEnergising your workforce in the face of adversity
Energising your workforce in the face of adversity
 
Shifting the balance of care: great expectations
Shifting the balance of care: great expectations Shifting the balance of care: great expectations
Shifting the balance of care: great expectations
 
Automation, Employment, and Health Care
Automation, Employment, and Health Care Automation, Employment, and Health Care
Automation, Employment, and Health Care
 
Public perspectives on the NHS and social care
Public perspectives on the NHS and social carePublic perspectives on the NHS and social care
Public perspectives on the NHS and social care
 
Evaluation of the Integrated Care and Support Pioneers Programme
Evaluation of the Integrated Care and Support Pioneers ProgrammeEvaluation of the Integrated Care and Support Pioneers Programme
Evaluation of the Integrated Care and Support Pioneers Programme
 
Ensuring success for new models of care
Ensuring success for new models of careEnsuring success for new models of care
Ensuring success for new models of care
 
Effectiveness of the current dominant approach to integrated care in the NHS
Effectiveness of the current dominant approach to integrated care in the NHSEffectiveness of the current dominant approach to integrated care in the NHS
Effectiveness of the current dominant approach to integrated care in the NHS
 
Providing actionable healthcare analytics at scale: Understanding improvement...
Providing actionable healthcare analytics at scale: Understanding improvement...Providing actionable healthcare analytics at scale: Understanding improvement...
Providing actionable healthcare analytics at scale: Understanding improvement...
 
Local and national uses of data
Local and national uses of dataLocal and national uses of data
Local and national uses of data
 
Applied use of CUSUMs in surveillance
Applied use of CUSUMs in surveillanceApplied use of CUSUMs in surveillance
Applied use of CUSUMs in surveillance
 
Engaging with data
Engaging with dataEngaging with data
Engaging with data
 
Evaluating new models of care: Improvement Analytics Unit
Evaluating new models of care: Improvement Analytics UnitEvaluating new models of care: Improvement Analytics Unit
Evaluating new models of care: Improvement Analytics Unit
 
Learning from the Care Quality Commission
Learning from the Care Quality CommissionLearning from the Care Quality Commission
Learning from the Care Quality Commission
 
Real-time monitoring and the data trap
Real-time monitoring and the data trapReal-time monitoring and the data trap
Real-time monitoring and the data trap
 
Monitoring quality of care: making the most of data
Monitoring quality of care: making the most of dataMonitoring quality of care: making the most of data
Monitoring quality of care: making the most of data
 
Providing actionable healthcare analytics at scale: Insights from the Nationa...
Providing actionable healthcare analytics at scale: Insights from the Nationa...Providing actionable healthcare analytics at scale: Insights from the Nationa...
Providing actionable healthcare analytics at scale: Insights from the Nationa...
 
Providing actionable healthcare analytics at scale: A perspective from stroke...
Providing actionable healthcare analytics at scale: A perspective from stroke...Providing actionable healthcare analytics at scale: A perspective from stroke...
Providing actionable healthcare analytics at scale: A perspective from stroke...
 
New Models of General Practice: Practical and policy lessons
New Models of General Practice: Practical and policy lessonsNew Models of General Practice: Practical and policy lessons
New Models of General Practice: Practical and policy lessons
 

Recently uploaded

Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...narwatsonia7
 
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort Service
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort ServiceCollege Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort Service
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort ServiceNehru place Escorts
 
Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service BangaloreCall Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalorenarwatsonia7
 
Book Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbers
Book Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbersBook Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbers
Book Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbersnarwatsonia7
 
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...Miss joya
 
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% SafeBangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safenarwatsonia7
 
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...Miss joya
 
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service MumbaiVIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbaisonalikaur4
 
Hemostasis Physiology and Clinical correlations by Dr Faiza.pdf
Hemostasis Physiology and Clinical correlations by Dr Faiza.pdfHemostasis Physiology and Clinical correlations by Dr Faiza.pdf
Hemostasis Physiology and Clinical correlations by Dr Faiza.pdfMedicoseAcademics
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
Asthma Review - GINA guidelines summary 2024
Asthma Review - GINA guidelines summary 2024Asthma Review - GINA guidelines summary 2024
Asthma Review - GINA guidelines summary 2024Gabriel Guevara MD
 
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...narwatsonia7
 
Call Girls Thane Just Call 9910780858 Get High Class Call Girls Service
Call Girls Thane Just Call 9910780858 Get High Class Call Girls ServiceCall Girls Thane Just Call 9910780858 Get High Class Call Girls Service
Call Girls Thane Just Call 9910780858 Get High Class Call Girls Servicesonalikaur4
 
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...Miss joya
 
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Call Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment Booking
Call Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment BookingCall Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment Booking
Call Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment BookingNehru place Escorts
 
Book Call Girls in Yelahanka - For 7001305949 Cheap & Best with original Photos
Book Call Girls in Yelahanka - For 7001305949 Cheap & Best with original PhotosBook Call Girls in Yelahanka - For 7001305949 Cheap & Best with original Photos
Book Call Girls in Yelahanka - For 7001305949 Cheap & Best with original Photosnarwatsonia7
 
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiCall Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiNehru place Escorts
 
Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 

Recently uploaded (20)

Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
 
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort Service
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort ServiceCollege Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort Service
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort Service
 
Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service BangaloreCall Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
 
Book Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbers
Book Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbersBook Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbers
Book Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbers
 
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
 
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% SafeBangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
 
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
 
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
 
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service MumbaiVIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
 
Hemostasis Physiology and Clinical correlations by Dr Faiza.pdf
Hemostasis Physiology and Clinical correlations by Dr Faiza.pdfHemostasis Physiology and Clinical correlations by Dr Faiza.pdf
Hemostasis Physiology and Clinical correlations by Dr Faiza.pdf
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
Asthma Review - GINA guidelines summary 2024
Asthma Review - GINA guidelines summary 2024Asthma Review - GINA guidelines summary 2024
Asthma Review - GINA guidelines summary 2024
 
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
 
Call Girls Thane Just Call 9910780858 Get High Class Call Girls Service
Call Girls Thane Just Call 9910780858 Get High Class Call Girls ServiceCall Girls Thane Just Call 9910780858 Get High Class Call Girls Service
Call Girls Thane Just Call 9910780858 Get High Class Call Girls Service
 
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
 
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
 
Call Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment Booking
Call Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment BookingCall Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment Booking
Call Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment Booking
 
Book Call Girls in Yelahanka - For 7001305949 Cheap & Best with original Photos
Book Call Girls in Yelahanka - For 7001305949 Cheap & Best with original PhotosBook Call Girls in Yelahanka - For 7001305949 Cheap & Best with original Photos
Book Call Girls in Yelahanka - For 7001305949 Cheap & Best with original Photos
 
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiCall Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
 
Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Available
 

Jonathan Weiner: Risk adjustment opportunities and challenges: US and UK experiences

  • 1. Risk adjustment opportunities and challenges: US and UK experiences Professor Jonathan P. Weiner Johns Hopkins Bloomberg School of Public Health Baltimore Maryland, USA Jweiner@jhsph.edu Presented at Nuffield Trust Conference, London, 29/6/11 © Copyright 2011 Johns Hopkins University,.
  • 2. A bit about me 2 Jonathan Weiner, DrPH From The Johns Hopkins University  Professor of Health Policy & Management  Professor of Health Informatics  CEO of the Johns Hopkins ACG R&D Team, based at University © Copyright 2011, Johns Hopkins University,.
  • 3. During the next 25 minutes I will offer some insights into: 3 • The conceptual domains of risk adjustment / case-mix / predictive modeling. • The Johns Hopkins ACG risk adjustment / predictive modeling method. • Experiences with risk adjustment applications in the US & UK related to budgeting / financing and beyond. • Some issues, opportunities and challenges associated with risk adjustment in the English primary care context. © Copyright 2011, Johns Hopkins University,.
  • 4. Risk adjustment is necessary because not all persons have the same need for health care 4 Percent of Health Percent of Care Resources Population Consumed 1% 30% 10% 70% 50% 97% © Copyright 2011, Johns Hopkins University,.
  • 5. Working Definitions 5 • Case mix / risk adjustment (RA) - taking health status / risk into consideration for health care finance, payment, provider performance assessment and patient outcome monitoring. • Predictive modeling (PM) - prospective (or concurrent) application of risk measures and statistical technique to identify “high risk” individuals who would likely benefit from care management interventions. 5 © Copyright 2011, Johns Hopkins University,.
  • 6. Co-Morbidity is key – Multiple morbidities encountered in UK GP practices 6 Average consultation in elderly involves someone with 1.9 QOF diseases and 6.7 chronic diseases using ACG/EDC chronic disease designations Source: Salisbury et al. From GPRD data, 488 practices 2005-2008 © Copyright 2011, Johns Hopkins University,.
  • 7. Co-morbidities are the norm for those with common “index” chronic conditions 7 (US 65+) Diabetes 9% 22% 21% 21% 27% Heart Disease 11% 21% 25% 24% 19% Arthritis 12% 22% 23% 22% 21% Hypertension 17% 24% 23% 20% 16% 0% 20% 40% 60% 80% 100% Single Condition Condition + 1 Condition + 2 Condition + 3 Condition + 4+ Source: From US Medicare (65+) data . Partnership for Solutions, Johns Hopkins University © Copyright 2011, Johns Hopkins University,.
  • 8. Co-morbidities are central to understanding resource use: ACG risk levels and patterns of 8 resource use at an English PCT Level of Co- % of Hospital Est. % of Avg. # Avg. # morbidity PCT’s Use Admissions Out- Prescripti (Based on Pop. Relative at PCT Patient ons / Yr. ACGs) Ratio Episodes / Yr. High 2% 11.5 25% 11.0 93 Moderate 17% 3.0 47% 7.1 66 Low 40% .6 26% 3.0 28 None 41% >.1 2% .5 6 Data from several large GP practices within PCT for 2005. N= 20,500 all ages. © Copyright 2011, Johns Hopkins University,. 8
  • 9. Johns Hopkins ACGs - 1 9 • One of first case-mix / risk adjustment method for categorizing diagnosis codes outside of hospitals. • 30 years of ongoing R&D at Johns Hopkins. • Original version based on primary care morbidity patterns (ADGs) developed by Prof. Barbara Starfield. • Billions of dollars per year are now routinely exchanged using ACGs in US, Canada, Spain, Sweden and other nations. • Care of 80+ million patients is budgeted, managed and monitored using ACGs in 16+ nations. © Copyright 2011, Johns Hopkins University,.
  • 10. Johns Hopkins ACGs - 2 10 • Comprehensive measure of a population’s risk and morbidity burden. They do not just categorize organ system-based diseases. • Roots were primary care / population based. • New collaboration with WONCA to integrate ACGs with ICPC. • Method owned and maintained by University. • There is a comprehensive computerized suite of ACG measures using most international diagnosis and pharmacy codes. © Copyright 2011, Johns Hopkins University,.
  • 11. Key components of the Johns Hopkins ACG System (www.acg.jhsph.edu) 11 ADGs 32 Patient Info ID – Age – Gender – Resource Use ACGs 102 / 6 Diagnosis ACG EDCs Predictive Read- ICD 9 - ICD 10 - ICPC System 220 / 30 Models Markers Frailty – Hosdom – Chronic Pharmaceuticals Pregnancy - Delivery ATC, Read, BNF Rx-MG 60 © Copyright 2011, Johns Hopkins University,.
  • 12. ACG System Use in the NHS (Currently 6+ million pts. across 12 PCTs) 12 • 2001 - Academic research at UCL and Imperial using GPRD data. • 2005 – Initial pilot project with 3 PCTs (w/ Imperial) • 2007 – Collaborated with King’s Fund on the Person Based Resource Allocation (PBRA) project • 2008 – Ashton, Leigh, and Wigan PCT • 2009 –North Yorkshire and York PCTs • 2010 – South Central – 9 PCTs (150 practices with uptake increasing) • 2011- Sutton & Merton PCT • Universities: Imperial College, UCL, Bristol, Manchester, Glasgow. • Several academics groups and many other PCTs / NHS organizations have expressed interest. © Copyright 2011, Johns Hopkins University,.
  • 13. The Risk Adjustment “Application Pyramid” 13 Management Applications High Case- Disease Management Burden Disease Needs Single High Management Practice Assessment Impact Resource Disease Management Quality Improvement Users Payment/ Finance Users & Non-Users Population Segment © Copyright 2011, Johns Hopkins University,.
  • 14. Types of risk adjustment applications within health care 14  Financing, Payment,  Care Management Planning  Identification of high risk  Morbidity-adjusted patient capitation  Disease management  Allocation of budgets  Case management  Service targets  Quality Forecasting healthcare  Quality assessment spending  Quality monitoring  Provider Performance  Research and Program Assessment Evaluation  Profiling  Pay-for-Performance © Copyright 2011, Johns Hopkins University,.
  • 15. 15 FINANCING, PAYMENT, RESOURCE PLANNING © Copyright 2011, Johns Hopkins University,.
  • 16. Resource Use Varies by Risk of GP Patients: NHS Consultant Referral Rates by Morbidity Score 16 50 40 % Patients referred per year to one 30 or more consultants 20 10 0.5 1.0 1.5 2.0 2.5 ACG Morbidity Score Source: Forrest, Majeed, Weiner, et al. BMJ 2002: 325;370 © Copyright 2011, Johns Hopkins University,. 16
  • 17. Morbidity Risk Scores (RUBs) Across GP practices in a PCT
  • 18. And these risk levels vary across communities served by practices in this PCT
  • 19. State of Minnesota “Health Care Home” program pays a monthly care coordination fee based on 5 patient complexity tiers 19 Source: Minnesota Department of Health 2010. PMPM = per member per month. Patient complexity tiers based on ACG/EDC categories. © Copyright 2011, Johns Hopkins University,.
  • 20. Maryland Medicaid risk adjusted (ACG) payment to capitated “HMO” health plans 20 Average Risk Using ACGs, risk ratios were determined for each contracting managed care organization / health plan. Expected values were determined separately for the two enrollee groups with this State Medicaid program. © Copyright 2011, Johns Hopkins University,.
  • 21. Some potential financial applications within context of English PCTs, GPCCs, Clusters, GP practices (etc.) 21 • Setting aspects of budgets for GP Consortia / GP practices. • To help GPCCs determine the budgets for downstream health care commissioning. • Monitor resource use and adjusting various pay for performance “P4P” performance measures. • Special payment to GPs or others for special need patients. • Adjusting/stratifying cases or episode payments as part of commissioning of secondary services. © Copyright 2011, Johns Hopkins University,.
  • 22. 22 PROVIDER PERFORMANCE ASSESSMENT © Copyright 2011, Johns Hopkins University,.
  • 23. Risk-Adjusted O/E (Efficiency) Profiling Ratios for GPs Across a Primary Care Trust (PCT) in UK 23 2.0 1.8 1.6 1.4 1.2 1.0 0.8 0.6 0.4 0.2 0.0 GP1 GP2 GP3 GP4 GP5 GP6 GP7 GP8 GP9 GP10 GP11 GP12 No of referrals No of unique prescriptions / month No of unique radiology tests Observed = actual avg. use by patients. Expected = based on ACG case-mix of pts. Above 1.0 = higher than expected. © Copyright 2011, Johns Hopkins University,.
  • 24. Comparison of Risk Adusted (ACG) and Age/Gender-based O:E Ratios for GPs across 24 Province of British Columbia Canada © Copyright 2011, Johns Hopkins University,.
  • 25. 25 CARE MANAGEMENT AND HIGH RISK PATIENT IDENTIFICATION © Copyright 2011, Johns Hopkins University,.
  • 26. Using risk stratification to target disease management program participation for chronic conditions 26 % Enrollees in ACG Risk Resource Use of Cohort Category Relative to Total Population Condition of Low Med. High Low Med. High Interest Diabetes 44.97 42.1 11.9 1.34 4.90 7.44 Congestive Heart 19.75 53.5 26.75 1.14 6.02 7.93 Failure Tier 1 Tier 2 Tier 3 © Copyright 2011, Johns Hopkins University,. 26
  • 27. Long-term conditions for GP practice by RUB co morbidity strata
  • 28. Care Management ACG report for a GP’s “high risk” Patient in GPCC / PCT
  • 29. Possible applications of PM / RA for improving care & accountability in England 29 • To comprehensively assess the needs of communities and special populations • Long-term (chronic) conditions • Disparities / social need. • To support “predictive” case finding to improve coordination and avoid unnecessary hospital and other types of care. • By regulators /evaluators to fairly monitor outcomes and financial performance. © Copyright 2011, Johns Hopkins University,.
  • 30. 30 SOME ISSUES AND OBSERVATIONS © Copyright 2011, Johns Hopkins University,.
  • 31. Data Accuracy Issues: Condition identification using GP diagnosis and pharmacy data from EMRs. Also 31 comparison to US results using 1º + 2º provider claims. % UK % UK and US % UK patients patients patients uniquely Condition identified identified by identified by (ICD or GP GP pharm.) diagnoses* prescriptions Hypertension 13%, 19% 5.0% 8.1% Disorders of Lipoid metabolism 5%, 15% 1.5% 3.8% CHF 3%, 2% .2% 2.3% Asthma 9%, 10% 4.4% 4.4% Depression 6%, 10% 1.6% 4.6% Diabetes 4%, 5% 3.9% .1% UK results from two PCTs w/2005 data, n=500K, based on ACG’s EDCs and RxMGs. US results based on 2M health plan sample using both primary and secondary care claims. *Many pts. had both diagnosis and pharmacy codes. © Copyright 2011, Johns Hopkins University,.
  • 32. NHS Reform will lead to opportunities for expanding the use of risk adjustment and predictive modeling tools 32 • The English reform plans include many shifts in paradigms that will enable RA and PM tools to have a positive impact on system efficiency, effectiveness and equity. • Many innovations are possible in English context that could allow us to improve the state-of-the-art of risk adjustment (e.g., social care integration, application of electronic patient records). • There is considerable overlap between GPCCs and aspects of past and current US reform. There are lessons and synergies in risk adjustment domain and beyond. © Copyright 2011, Johns Hopkins University,.
  • 33. There will also be challenges related to the application of RA/PM 33 • Need to integrate risk adjustment / predictive modeling into dynamically changing (and charged) administrative and fiscal situation. • There will be many challenges associated with integrating and using data that previously had other purposes. • Some cautions: be wary of “code creep”, maintaining zero sum game, negative impact of potential pharmacy code gaming. © Copyright 2011, Johns Hopkins University,.
  • 34. Need for risk adjustment is universal, but of course all of this will be impacted by future polices in both nations 34 © Copyright 2011, Johns Hopkins University,. 34
  • 35. For more information on Johns Hopkins experiences and tools 35 • Johns Hopkins web site: – www.acg.jhsph.edu • Contacts: – Dr. Karen Kinder: Director, ACG International (Based in Germany) kkinder@jhsph.edu – Steve Sutch: Senior ACG Consultant (based in England) ssutch@jhsph.edu © Copyright 2011, Johns Hopkins University,.